• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6,198
2,060
2,029
1,681
1,493

COUNTRY

1,004
805
244
232
188

CATEGORIES

  • 907
  • 187
  • 123
  • 326
  • 464
  • 233
  • 259
  • 65
  • 78
  • 808
  • 1,428
  • 855
  • 24
  • 449
  • 1,317
  • 2,286
  • 25
  • 271
  • 49

PRICE

4,944
10,260
19,377
25,564

PUBLISHED

1,526
5,561
9,544
25,564

PRODUCT TYPE

21,455
1,951
1,008
889
164
37
21
21
11
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2014

Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Venous Leg Ulcers (Crural ulcer) - Pipeline Review, H1 2014’, provides an overview of the Venous Leg Ulcers...

February 2014
FROM

Medullary Thyroid Cancer - Pipeline Review, H1 2014

Medullary Thyroid Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H1 2014’, provides an overview of the Medullary Thyroid Cancer’s therapeutic...

February 2014
FROM

EVP-6124 (Schizophrenia) - Forecast and Market Analysis to 2022

EVP-6124 (Schizophrenia) - Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its core symptoms,...

February 2014
FROM

PharmaPoint: Schizophrenia - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Schizophrenia - Japan Drug Forecast and Market Analysis to 2022 Summary Schizophrenia is a persistent long-term brain disorder that causes severe, debilitating psychotic episodes. Its...

February 2014
FROM

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Cytomegalovirus (HHV-5) Infections - Pipeline Review, H1 2014’, provides an overview of the Cytomegalovirus...

February 2014
FROM

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2014’, provides an overview of the Gastrointestinal...

February 2014
FROM

Substance (Drug) Abuse - Pipeline Review, H1 2014

Substance (Drug) Abuse - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Substance (Drug) Abuse - Pipeline Review, H1 2014’, provides an overview of the Substance (Drug) Abuse’s therapeutic...

February 2014
FROM

Essential Thrombocythemia - Pipeline Review, H1 2014

Essential Thrombocythemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Essential Thrombocythemia - Pipeline Review, H1 2014’, provides an overview of the Essential Thrombocythemia’s...

February 2014
FROM

Duchenne Muscular Dystrophy - Pipeline Review, H1 2014

Duchenne Muscular Dystrophy - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2014’, provides an overview of the Duchenne Muscular Dystrophy’s...

February 2014
FROM

Mantle Cell Lymphoma - Pipeline Review, H1 2014

Mantle Cell Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mantle Cell Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Mantle Cell Lymphoma’s therapeutic pipeline. This...

February 2014
FROM

Drug Addiction - Pipeline Review, H1 2014

Drug Addiction - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Drug Addiction - Pipeline Review, H1 2014’, provides an overview of the Drug Addiction’s therapeutic pipeline. This report...

February 2014
FROM

Acute Pain - Pipeline Review, H1 2014

Acute Pain - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Acute Pain - Pipeline Review, H1 2014’, provides an overview of the Acute Pain’s therapeutic pipeline. This report provides...

February 2014
FROM

Brain Cancer - Pipeline Review, H1 2014

Brain Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H1 2014’, provides an overview of the Brain Cancer’s therapeutic pipeline. This report provides...

February 2014
FROM

Follicular Lymphoma - Pipeline Review, H1 2014

Follicular Lymphoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2014’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline. This...

February 2014
FROM

Ewing Sarcoma - Pipeline Review, H1 2014

Ewing Sarcoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Ewing Sarcoma - Pipeline Review, H1 2014’, provides an overview of the Ewing Sarcoma’s therapeutic pipeline. This report...

February 2014
FROM

Febrile Neutropenia - Pipeline Review, H1 2014

Febrile Neutropenia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Febrile Neutropenia - Pipeline Review, H1 2014’, provides an overview of the Febrile Neutropenia’s therapeutic pipeline. This...

February 2014
FROM

Small-Cell Lung Cancer - Pipeline Review, H1 2014

Small-Cell Lung Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2014’, provides an overview of the Small-Cell Lung Cancer’s therapeutic...

February 2014
FROM

Refractory Multiple Myeloma - Pipeline Review, H1 2014

Refractory Multiple Myeloma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2014’, provides an overview of the Refractory Multiple Myeloma’s...

February 2014
FROM

Medulloblastoma - Pipeline Review, H1 2014

Medulloblastoma - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2014’, provides an overview of the Medulloblastoma’s therapeutic pipeline. This...

February 2014
FROM

Hypertrophic Scars - Pipeline Review, H1 2014

Hypertrophic Scars - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hypertrophic Scars - Pipeline Review, H1 2014’, provides an overview of the Hypertrophic Scars’s therapeutic pipeline. This...

February 2014
FROM
Loading Indicator

Our Clients

Our clients' logos